Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide
- 30 September 1986
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 8 (3), 607-615
- https://doi.org/10.1016/s0735-1097(86)80190-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Treatment of resistant ventricular tachycardia with flecainide acetateThe American Journal of Cardiology, 1986
- Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmiasThe American Journal of Cardiology, 1985
- Antiarrhythmic drug classification: New science and practical applicationsThe American Journal of Cardiology, 1985
- Premature Ventricular ComplexesJAMA, 1984
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardiaJournal of the American College of Cardiology, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.Circulation, 1982
- Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainideThe American Journal of Cardiology, 1981
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasThe New England Journal of Medicine, 1981